Olmesartan Medoxomil NDC 31722-853

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-853Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0853Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
31722-853-30	31722085330	30 TABLET, FILM COATED in 1 BOTTLE (31722-853-30)Marketed from May 23, 2025
31722-853-90	31722085390	90 TABLET, FILM COATED in 1 BOTTLE (31722-853-90)Marketed from May 23, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Olmesartan Medoxomil
Generic name (nonproprietary): olmesartan medoxomil
Active ingredients: Olmesartan medoxomil — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205499
Marketing start: May 23, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 31722-853_35cb69e0-7e6c-d4ee-e063-6294a90ae48cSPL ID 35cb69e0-7e6c-d4ee-e063-6294a90ae48cSPL set ID 53b8d406-a4f3-46ee-9aec-d70f7d806876RxCUI 349373, 349401, 349405UNII 6M97XTV3HDUPC 0331722854306, 0331722852302, 0331722853309
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722085330 followed by a unit qualifier and the quantity

Package 31722-0853-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 23, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Olmesartan medoxomil tablets are indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, d…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205499

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205499
Product	Strength	Form · route	Labeler	Product NDC
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-852
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-854